Update on managing hypercholesterolemia. The new NCEP guidelines.
作者： Marsha Bernard Kuhar
DOI: 10.1177/216507990205000808
关键词:
摘要: 1. The Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment High Blood in Adults (ATPIII) will significantly increase number Americans treated for hypercholesterolemia. 2. ATPIII focuses lowering low density lipoprotein cholesterol as a primary initiative using exercise, diet, pharmacotherapy means coronary heart disease risks. 3. new guidelines list levels less than 100 mg/dL optimal all clients. 4. places increased attention high triglyceride (> 200 mg/dL) early detection appropriate aggressive treatment clients at risk events.
sagepub.com
sci-hub.se 参考文章(7)
Patricia R. Hebert, Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality JAMA. ,vol. 278, pp. 313- 321 ,(1997) , 10.1001/JAMA.1997.03550040069040
Gerd Assmann, Helmut Schulte, Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study. American Journal of Cardiology. ,vol. 70, pp. 733- 737 ,(1992) , 10.1016/0002-9149(92)90550-I
Scott M. Grundy, Small LDL, atherogenic dyslipidemia, and the metabolic syndrome Circulation. ,vol. 95, pp. 1- 4 ,(1997) , 10.1161/01.CIR.95.1.1
Thomas J. Ryan, Elliott M. Antman, Neil H. Brooks, Robert M. Califf, L. David Hillis, Loren F. Hiratzka, Elliot Rapaport, Barbara Riegel, Richard O. Russell, Earl E. Smith, W. Douglas Weaver, Raymond J. Gibbons, Joseph S. Alpert, Kim A. Eagle, Timothy J. Gardner, Arthur Garson, Gabriel Gregoratos, Richard O. Russell, Thomas J. Ryan, Sidney C. Smith, 1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Circulation. ,vol. 100, pp. 1016- 1030 ,(1999) , 10.1161/01.CIR.100.9.1016
J. E. Hokanson, M. A. Austin, Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk. ,vol. 3, pp. 213- 219 ,(1996) , 10.1177/174182679600300214
Herbert D Aronow, Eric J Topol, Matthew T Roe, Penny L Houghtaling, Katherine E Wolski, A Michael Lincoff, Robert A Harrington, Robert M Califf, E Magnus Ohman, Neal S Kleiman, Matyas Keltai, Robert G Wilcox, Alec Vahanian, Paul W Armstrong, Michael S Lauer, Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study The Lancet. ,vol. 357, pp. 1063- 1068 ,(2001) , 10.1016/S0140-6736(00)04257-4
Hanna Bloomfield Rubins, Sander J. Robins, Dorothea Collins, Carol L. Fye, James W. Anderson, Marshall B. Elam, Fred H. Faas, Esteban Linares, Ernst J. Schaefer, Gordon Schectman, Timothy J. Wilt, Janet Wittes, Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol The New England Journal of Medicine. ,vol. 341, pp. 410- 418 ,(1999) , 10.1056/NEJM199908053410604